Literature DB >> 21926327

Resistance to regulatory T cell-mediated suppression in rheumatoid arthritis can be bypassed by ectopic foxp3 expression in pathogenic synovial T cells.

Paul A Beavis1, Bernard Gregory, Patricia Green, Adam P Cribbs, Alan Kennedy, Parisa Amjadi, Andrew C Palfreeman, Marc Feldmann, Fionula M Brennan.   

Abstract

Increasing evidence suggests that regulatory T cell (Treg) function is impaired in chronic inflammatory diseases such as rheumatoid arthritis (RA). Here we demonstrate that Tregs are unable to modulate the spontaneous production of TNF-α from RA synovial cells cultured from the diseased synovium site. Cytokine (IL-2, IL-6, TNF-α) activated T cells (Tck), cells we previously demonstrated to mimic the effector function of pathogenic RA synovial T cells, contained Tregs that survived and divided in this cytokine environment; however, the up-regulation of key molecules associated with Treg function (CTLA-4 and LFA-1) was impaired. Furthermore, Tregs were unable to suppress the function of Tcks, including contact-dependent induction of TNF-α from macrophages, supporting the concept that impaired Treg function/responsiveness contributes to chronicity of RA. However, ectopic foxp3 expression in both Tcks and pathogenic RA synovial T cells attenuated their cytokine production and function, including contact-dependent activation of macrophages. This diminished response to cytokine activation after ectopic foxp3 expression involved inhibited NF-κB activity and differed mechanistically from that displayed endogenously in conventional Tregs. These results suggest that diseases such as RA may perpetuate owing to the inability of Tregs to control cytokine-activated T-cell function. Understanding the mechanism whereby foxp3 attenuates the pathogenic function of synovial T cells may provide insight into the mechanisms of chronicity in inflammatory disease and potentially reveal new therapeutic candidates.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21926327      PMCID: PMC3189031          DOI: 10.1073/pnas.1112722108

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  57 in total

1.  Gene therapy of arthritis with TCR isolated from the inflamed paw.

Authors:  Keishi Fujio; Akiko Okamoto; Yasuto Araki; Hirofumi Shoda; Hiroyuki Tahara; Nelson H Tsuno; Koki Takahashi; Toshio Kitamura; Kazuhiko Yamamoto
Journal:  J Immunol       Date:  2006-12-01       Impact factor: 5.422

2.  IL-1 beta breaks tolerance through expansion of CD25+ effector T cells.

Authors:  Brendan J O'Sullivan; Helen E Thomas; Saparna Pai; Pere Santamaria; Yoichiro Iwakura; Raymond J Steptoe; Thomas W H Kay; Ranjeny Thomas
Journal:  J Immunol       Date:  2006-06-15       Impact factor: 5.422

3.  IL-21 counteracts the regulatory T cell-mediated suppression of human CD4+ T lymphocytes.

Authors:  Ilaria Peluso; Massimo Claudio Fantini; Daniele Fina; Roberta Caruso; Monica Boirivant; Thomas T MacDonald; Francesco Pallone; Giovanni Monteleone
Journal:  J Immunol       Date:  2007-01-15       Impact factor: 5.422

4.  Proinflammatory mediator-induced reversal of CD4+,CD25+ regulatory T cell-mediated suppression in rheumatoid arthritis.

Authors:  Jocea M R van Amelsfort; Joel A G van Roon; Madelon Noordegraaf; Kim M G Jacobs; Johannes W J Bijlsma; Floris P J G Lafeber; Leonie S Taams
Journal:  Arthritis Rheum       Date:  2007-03

5.  Enhanced efficacy of regulatory T cell transfer against increasing resistance, by elevated Foxp3 expression induced in arthritic murine hosts.

Authors:  Junko Ohata; Tomoko Miura; Todd A Johnson; Shohei Hori; Steven F Ziegler; Hitoshi Kohsaka
Journal:  Arthritis Rheum       Date:  2007-09

6.  Differential expression of CD126 and CD130 mediates different STAT-3 phosphorylation in CD4+CD25- and CD25high regulatory T cells.

Authors:  Hans-Heinrich Oberg; Daniela Wesch; Sandra Grüssel; Stefan Rose-John; Dieter Kabelitz
Journal:  Int Immunol       Date:  2006-03-15       Impact factor: 4.823

7.  Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production.

Authors:  Sarah E Allan; Sarah Q Crome; Natasha K Crellin; Laura Passerini; Theodore S Steiner; Rosa Bacchetta; Maria G Roncarolo; Megan K Levings
Journal:  Int Immunol       Date:  2007-02-27       Impact factor: 4.823

8.  T-cell contact-dependent regulation of CC and CXC chemokine production in monocytes through differential involvement of NFkappaB: implications for rheumatoid arthritis.

Authors:  Jonathan T Beech; Evangelos Andreakos; Cathleen J Ciesielski; Patricia Green; Brian M J Foxwell; Fionula M Brennan
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

9.  Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice.

Authors:  Kristin V Tarbell; Lucine Petit; Xiaopan Zuo; Priscilla Toy; Xunrong Luo; Amina Mqadmi; Hua Yang; Manikkam Suthanthiran; Svetlana Mojsov; Ralph M Steinman
Journal:  J Exp Med       Date:  2007-01-08       Impact factor: 14.307

10.  Anti-TNF-alpha therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-beta.

Authors:  Suchita Nadkarni; Claudia Mauri; Michael R Ehrenstein
Journal:  J Exp Med       Date:  2007-01-02       Impact factor: 14.307

View more
  23 in total

1.  Suppression of murine colitis and its associated cancer by carcinoembryonic antigen-specific regulatory T cells.

Authors:  Dan Blat; Ehud Zigmond; Zoya Alteber; Tova Waks; Zelig Eshhar
Journal:  Mol Ther       Date:  2014-03-06       Impact factor: 11.454

2.  Dynamic Immune Phenotypes of B and T Helper Cells Mark Distinct Stages of T1D Progression.

Authors:  Tania Habib; S Alice Long; Peter L Samuels; Archana Brahmandam; Megan Tatum; Andrew Funk; Anne M Hocking; Karen Cerosaletti; Michael T Mason; Elizabeth Whalen; David J Rawlings; Carla Greenbaum; Jane H Buckner
Journal:  Diabetes       Date:  2019-03-20       Impact factor: 9.461

3.  Methylation of the FOXP3 upstream enhancer as a clinical indicator of defective regulatory T cells in patients with acute coronary syndrome.

Authors:  Jun Yang; Xiaoyang Yuan; Caixia Lv; Rong Bai; Le Zhang; Lei Ruang; Cuntai Zhang; Xiao-Qing Quan
Journal:  Am J Transl Res       Date:  2016-12-15       Impact factor: 4.060

4.  Predictors of survival in coexistent hypersensitivity pneumonitis with autoimmune features.

Authors:  Ayodeji Adegunsoye; Justin M Oldham; Carley Demchuk; Steven Montner; Rekha Vij; Mary E Strek
Journal:  Respir Med       Date:  2016-03-21       Impact factor: 3.415

5.  The Hypermethylation of Foxp3 Promoter Impairs the Function of Treg Cells in EAP.

Authors:  Jing Chen; Changsheng Zhan; Li Zhang; Ligang Zhang; Yi Liu; Yong Zhang; Hexi Du; Chaozhao Liang; Xianguo Chen
Journal:  Inflammation       Date:  2019-10       Impact factor: 4.092

6.  T Regulatory Cell Induced Foxp3 Binds the IL2, IFNγ, and TNFα Promoters in Virus-Specific CD8+ T Cells from Feline Immunodeficiency Virus Infected Cats.

Authors:  Yan Wang; Mukta Nag; Joanne L Tuohy; Kristina De Paris; Jonathan E Fogle
Journal:  AIDS Res Hum Retroviruses       Date:  2017-11-17       Impact factor: 2.205

7.  Cell-penetrable mouse forkhead box protein 3 alleviates experimental arthritis in mice by up-regulating regulatory T cells.

Authors:  Xia Liu; Baoju Ji; Mengyi Sun; Weijiang Wu; Lili Huang; Aihua Sun; Yangyong Zong; Sheng Xia; Liyun Shi; Hui Qian; Wenrong Xu; Qixiang Shao
Journal:  Clin Exp Immunol       Date:  2015-05-10       Impact factor: 4.330

8.  Sialic acid-modified antigens impose tolerance via inhibition of T-cell proliferation and de novo induction of regulatory T cells.

Authors:  Maurizio Perdicchio; Juan M Ilarregui; Marleen I Verstege; Lenneke A M Cornelissen; Sjoerd T T Schetters; Steef Engels; Martino Ambrosini; Hakan Kalay; Henrike Veninga; Joke M M den Haan; Lisette A van Berkel; Janneke N Samsom; Paul R Crocker; Tim Sparwasser; Luciana Berod; Juan J Garcia-Vallejo; Yvette van Kooyk; Wendy W J Unger
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-03       Impact factor: 11.205

Review 9.  Antigen-Specific Regulatory T Cell Therapy in Autoimmune Diseases and Transplantation.

Authors:  Claudia Selck; Margarita Dominguez-Villar
Journal:  Front Immunol       Date:  2021-05-14       Impact factor: 7.561

10.  Ectopic FOXP3 Expression in Combination with TGF-β1 and IL-2 Stimulation Generates Limited Suppressive Function in Human Primary Activated Thymocytes Ex Vivo.

Authors:  Jorge Gallego-Valle; Sergio Gil-Manso; Ana Pita; Esther Bernaldo-de-Quirós; Rocío López-Esteban; Marta Martínez-Bonet; Verónica Astrid Pérez-Fernández; Ramón Pérez-Caballero; Carlos Pardo; Juan-Miguel Gil-Jaurena; Rafael Correa-Rocha; Marjorie Pion
Journal:  Biomedicines       Date:  2021-04-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.